These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 19833760)

  • 21. Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis.
    Yanaba K; Hasegawa M; Takehara K; Sato S
    J Rheumatol; 2004 Jun; 31(6):1112-20. PubMed ID: 15170923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of ficolin-3 (Hakata antigen) in patients with systemic lupus erythematosus.
    Andersen T; Munthe-Fog L; Garred P; Jacobsen S
    J Rheumatol; 2009 Apr; 36(4):757-9. PubMed ID: 19208603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus.
    Kümpers P; David S; Haubitz M; Hellpap J; Horn R; Bröcker V; Schiffer M; Haller H; Witte T
    Ann Rheum Dis; 2009 Oct; 68(10):1638-43. PubMed ID: 18930996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
    Wais T; Fierz W; Stoll T; Villiger PM
    J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenic activity in sera of patients with systemic lupus erythematosus.
    Sakly N; Mirshahi P; Ducros E; Soria J; Ghedira I; Mirshahi M
    Lupus; 2009 Jul; 18(8):705-12. PubMed ID: 19502266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7.
    Williams RC; Malone CC; Meyers C; Decker P; Muller S
    J Rheumatol; 2001 Jan; 28(1):81-94. PubMed ID: 11196548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus.
    Rizzo R; Hviid TV; Govoni M; Padovan M; Rubini M; Melchiorri L; Stignani M; Carturan S; Grappa MT; Fotinidi M; Ferretti S; Voss A; Laustrup H; Junker P; Trotta F; Baricordi OR
    Tissue Antigens; 2008 Jun; 71(6):520-9. PubMed ID: 18380776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus.
    Biesen R; Demir C; Barkhudarova F; Grün JR; Steinbrich-Zöllner M; Backhaus M; Häupl T; Rudwaleit M; Riemekasten G; Radbruch A; Hiepe F; Burmester GR; Grützkau A
    Arthritis Rheum; 2008 Apr; 58(4):1136-45. PubMed ID: 18383365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.
    Bijl M; Bootsma H; Van Der Geld Y; Limburg PC; Kallenberg CG; Van Rijswijk MH
    Ann Rheum Dis; 2004 Jul; 63(7):831-5. PubMed ID: 15194579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum amyloid P component-DNA complexes are decreased in systemic lupus erythematosus. inverse association with anti-dsDNA antibodies.
    Voss A; Nielsen EH; Svehag SE; Junker P
    J Rheumatol; 2008 Apr; 35(4):625-30. PubMed ID: 18278838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus.
    Petri M; Stohl W; Chatham W; McCune WJ; Chevrier M; Ryel J; Recta V; Zhong J; Freimuth W
    Arthritis Rheum; 2008 Aug; 58(8):2453-9. PubMed ID: 18668552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of mannose-binding lectin gene polymorphisms with antiphospholipid syndrome, cardiovascular disease and chronic damage in patients with systemic lupus erythematosus.
    Font J; Ramos-Casals M; Brito-Zerón P; Nardi N; Ibañez A; Suarez B; Jiménez S; Tàssies D; García-Criado A; Ros E; Sentís J; Reverter JC; Lozano F
    Rheumatology (Oxford); 2007 Jan; 46(1):76-80. PubMed ID: 16801331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A role for mannose-binding lectin dysfunction in generation of autoantibodies in systemic lupus erythematosus.
    Seelen MA; van der Bijl EA; Trouw LA; Zuiverloon TC; Munoz JR; Fallaux-van den Houten FC; Schlagwein N; Daha MR; Huizinga TW; Roos A
    Rheumatology (Oxford); 2005 Jan; 44(1):111-9. PubMed ID: 15479757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p21 gene polymorphisms in systemic lupus erythematosus.
    Kong EK; Chong WP; Wong WH; Lau CS; Chan TM; Ng PK; Song YQ; Mak W; Lau YL
    Rheumatology (Oxford); 2007 Feb; 46(2):220-6. PubMed ID: 16837471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of serum C-reactive protein in systemic lupus erythematosus.
    Williams RC; Harmon ME; Burlingame R; Du Clos TW
    J Rheumatol; 2005 Mar; 32(3):454-61. PubMed ID: 15742436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: two case-control studies and a meta-analysis.
    Lee YH; Witte T; Momot T; Schmidt RE; Kaufman KM; Harley JB; Sestak AL
    Arthritis Rheum; 2005 Dec; 52(12):3966-74. PubMed ID: 16320344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus.
    Her M; Kim D; Oh M; Jeong H; Choi I
    Lupus; 2009 May; 18(6):501-7. PubMed ID: 19395451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial DNA polymorphisms are associated with susceptibility and phenotype of systemic lupus erythematosus.
    Jönsen A; Yu X; Truedsson L; Nived O; Sturfelt G; Ibrahim S; Bengtsson A
    Lupus; 2009 Apr; 18(4):309-12. PubMed ID: 19276298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperprolactinemia in males with systemic lupus erythematosus.
    Mok CC; Lau CS; Lee KW; Wong RW
    J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
    Morel J; Roubille C; Planelles L; Rocha C; Fernandez L; Lukas C; Hahne M; Combe B
    Ann Rheum Dis; 2009 Jun; 68(6):997-1002. PubMed ID: 18676986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.